KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Organigram Global (NASDAQ:OGI – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.
Profitability
This table compares KORU Medical Systems and Organigram Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -4.03% | -10.63% | -6.51% |
| Organigram Global | 28.14% | -13.39% | -8.67% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for KORU Medical Systems and Organigram Global, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 0 | 4 | 0 | 2.60 |
| Organigram Global | 1 | 0 | 2 | 0 | 2.33 |
Volatility & Risk
KORU Medical Systems has a beta of 0.43, suggesting that its share price is 57% less volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.49, suggesting that its share price is 49% more volatile than the S&P 500.
Earnings and Valuation
This table compares KORU Medical Systems and Organigram Global”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $45.11 million | 3.29 | -$2.64 million | ($0.04) | -80.75 |
| Organigram Global | $309.18 million | 0.48 | -$17.70 million | $0.46 | 2.28 |
KORU Medical Systems has higher earnings, but lower revenue than Organigram Global. KORU Medical Systems is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
KORU Medical Systems beats Organigram Global on 9 of the 14 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
